LISA KATULIS: Open Payments
NPI 1639715998 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $484 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $129 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| Gilead Sciences, Inc. | 2 | $47 |
| ABBVIE INC. | 1 | $32 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| TerSera Therapeutics LLC | 1 | $28 |
| SpringWorks Therapeutics, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $19 |
Products named: ELAHERE, Nubeqa, Stivarga, Xermelo, KEYTRUDA.
Industry payments across MD — which companies pay providers there.
